These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 34929213)
41. SEPT6 drives hepatocellular carcinoma cell proliferation, migration and invasion via the Hippo/YAP signaling pathway. Fan Y; Du Z; Ding Q; Zhang J; Op Den Winkel M; Gerbes AL; Liu M; Steib CJ Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33846777 [TBL] [Abstract][Full Text] [Related]
42. Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice. Wang J; Dong M; Xu Z; Song X; Zhang S; Qiao Y; Che L; Gordan J; Hu K; Liu Y; Calvisi DF; Chen X Oncogene; 2018 Jun; 37(24):3229-3242. PubMed ID: 29545603 [TBL] [Abstract][Full Text] [Related]
43. Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma. Tschaharganeh DF; Chen X; Latzko P; Malz M; Gaida MM; Felix K; Ladu S; Singer S; Pinna F; Gretz N; Sticht C; Tomasi ML; Delogu S; Evert M; Fan B; Ribback S; Jiang L; Brozzetti S; Bergmann F; Dombrowski F; Schirmacher P; Calvisi DF; Breuhahn K Gastroenterology; 2013 Jun; 144(7):1530-1542.e12. PubMed ID: 23419361 [TBL] [Abstract][Full Text] [Related]
44. Molecular evidence for better efficacy of hypocrellin A and oleanolic acid combination in suppression of HCC growth. Wang L; Wang J; Cao Y; Li W; Wang Y; Xu J; Xu G Eur J Pharmacol; 2019 Jan; 842():281-290. PubMed ID: 30391347 [TBL] [Abstract][Full Text] [Related]
45. Yes-associated protein expression is a predictive marker for recurrence of hepatocellular carcinoma after liver transplantation. Li H; Wang S; Wang G; Zhang Z; Wu X; Zhang T; Fu B; Chen G Dig Surg; 2014; 31(6):468-78. PubMed ID: 25632982 [TBL] [Abstract][Full Text] [Related]
46. Role of the transcriptional coactivators YAP/TAZ in liver cancer. Zhang S; Zhou D Curr Opin Cell Biol; 2019 Dec; 61():64-71. PubMed ID: 31387016 [TBL] [Abstract][Full Text] [Related]
47. RASSF1A-mediated regulation of AREG via the Hippo pathway in hepatocellular carcinoma. Ahn EY; Kim JS; Kim GJ; Park YN Mol Cancer Res; 2013 Jul; 11(7):748-58. PubMed ID: 23594797 [TBL] [Abstract][Full Text] [Related]
48. Yes-associated protein/TEA domain family member and hepatocyte nuclear factor 4-alpha (HNF4α) repress reciprocally to regulate hepatocarcinogenesis in rats and mice. Cai WY; Lin LY; Hao H; Zhang SM; Ma F; Hong XX; Zhang H; Liu QF; Ye GD; Sun GB; Liu YJ; Li SN; Xie YY; Cai JC; Li BA Hepatology; 2017 Apr; 65(4):1206-1221. PubMed ID: 27809333 [TBL] [Abstract][Full Text] [Related]
49. CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway. Yang N; Chen T; Wang L; Liu R; Niu Y; Sun L; Yao B; Wang Y; Yang W; Liu Q; Tu K; Liu Z Theranostics; 2020; 10(13):5790-5801. PubMed ID: 32483419 [No Abstract] [Full Text] [Related]
50. Tadalafil enhances the therapeutic efficacy of BET inhibitors in hepatocellular carcinoma through activating Hippo pathway. Kong D; Jiang Y; Miao X; Wu Z; Liu H; Gong W Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166267. PubMed ID: 34508829 [TBL] [Abstract][Full Text] [Related]
51. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress. Zhang X; Li Y; Ma Y; Yang L; Wang T; Meng X; Zong Z; Sun X; Hua X; Li H J Exp Clin Cancer Res; 2018 Sep; 37(1):216. PubMed ID: 30180863 [TBL] [Abstract][Full Text] [Related]
52. CIZ1 interacts with YAP and activates its transcriptional activity in hepatocellular carcinoma cells. Lei L; Wu J; Gu D; Liu H; Wang S Tumour Biol; 2016 Aug; 37(8):11073-9. PubMed ID: 26906552 [TBL] [Abstract][Full Text] [Related]
53. Yap promotes hepatocellular carcinoma metastasis and mobilization via governing cofilin/F-actin/lamellipodium axis by regulation of JNK/Bnip3/SERCA/CaMKII pathways. Shi C; Cai Y; Li Y; Li Y; Hu N; Ma S; Hu S; Zhu P; Wang W; Zhou H Redox Biol; 2018 Apr; 14():59-71. PubMed ID: 28869833 [TBL] [Abstract][Full Text] [Related]
54. Clinicopathological and prognostic significance of Yes-associated protein expression in hepatocellular carcinoma and hepatic cholangiocarcinoma. Wu H; Liu Y; Jiang XW; Li WF; Guo G; Gong JP; Ding X Tumour Biol; 2016 Oct; 37(10):13499-13508. PubMed ID: 27465555 [TBL] [Abstract][Full Text] [Related]
55. The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming. Liu Y; Ren H; Zhou Y; Shang L; Zhang Y; Yang F; Shi X J Exp Clin Cancer Res; 2019 May; 38(1):228. PubMed ID: 31142342 [TBL] [Abstract][Full Text] [Related]
56. The membrane protein melanoma cell adhesion molecule (MCAM) is a novel tumor marker that stimulates tumorigenesis in hepatocellular carcinoma. Wang J; Tang X; Weng W; Qiao Y; Lin J; Liu W; Liu R; Ma L; Yu W; Yu Y; Pan Q; Sun F Oncogene; 2015 Nov; 34(47):5781-95. PubMed ID: 25728681 [TBL] [Abstract][Full Text] [Related]
57. Loss of trefoil factor 1 inhibits biliary regeneration but accelerates the hepatic differentiation of progenitor cells in mice. Hayashi Y; Yamaguchi J; Kokuryo T; Ebata T; Yokoyama Y; Nagino M Biochem Biophys Res Commun; 2018 Nov; 506(1):12-19. PubMed ID: 30333090 [TBL] [Abstract][Full Text] [Related]
58. SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin-Rho GTPase-Hippo Pathways. Zhang YL; Li Q; Yang XM; Fang F; Li J; Wang YH; Yang Q; Zhu L; Nie HZ; Zhang XL; Feng MX; Jiang SH; Tian GA; Hu LP; Lee HY; Lee SJ; Xia Q; Zhang ZG Cancer Res; 2018 May; 78(9):2305-2317. PubMed ID: 29440144 [TBL] [Abstract][Full Text] [Related]
59. Oct4 Is Crucial for Transdifferentiation of Hepatocytes to Biliary Epithelial Cells in an In Vitro Organoid Culture Model. Doffou M; Adams G; Bowen WC; Paranjpe S; Parihar HS; Nguyen H; Michalopoulos GK; Bhave VS Gene Expr; 2018 Mar; 18(1):51-62. PubMed ID: 29212575 [TBL] [Abstract][Full Text] [Related]